These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children. Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R. Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979 [Abstract] [Full Text] [Related]
28. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, Linde A, Ringdén O, Wahren B. J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859 [Abstract] [Full Text] [Related]
36. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B. Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126 [Abstract] [Full Text] [Related]
37. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration. Christenson B, Böttiger M. J Biol Stand; 1985 Apr; 13(2):167-72. PubMed ID: 3997899 [Abstract] [Full Text] [Related]